Related Experiment Video
Updated: Aug 1, 2026

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
BRAF mutations in non-Hodgkin's lymphoma.
1Department of Pathology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul 137-701, Korea.
This study investigated BRAF mutations in non-Hodgkin's lymphoma (NHL). BRAF mutations were found in 2.4% of NHL cases, suggesting a potential role in lymphoma development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ras proteins are crucial regulators of cell growth and cancer development.
- BRAF, a downstream component of the Ras pathway, is frequently mutated in various human cancers.
- The role of BRAF mutations in non-Hodgkin's lymphoma (NHL) remained unexplored.
Purpose of the Study:
- To investigate the frequency and nature of BRAF gene mutations in a cohort of non-Hodgkin's lymphoma patients.
- To determine if BRAF mutations contribute to the pathogenesis of NHL.
Main Methods:
- Genomic DNA was extracted from 164 NHL samples.
- Polymerase chain reaction (PCR) coupled with single-strand conformation polymorphism (SSCP) was employed to screen for BRAF mutations.
- Exons 11 and 15 of the BRAF gene were analyzed for somatic mutations.
Main Results:
- BRAF mutations were identified in 4 out of 164 (2.4%) NHL cases.
- Unlike mutations typically found in other cancers (e.g., V599), all identified BRAF mutations in NHL occurred at different amino acid positions.
- Specific mutations detected included G468A (one case), G468R (two cases), and D593G (one case).
Conclusions:
- This study provides the first evidence of BRAF mutations in non-Hodgkin's lymphoma.
- BRAF mutations are infrequent but present in NHL.
- These findings suggest that BRAF mutations may play a role in the oncogenesis of a subset of NHL cases.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
07:17Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Related Concept Videos
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancers Originate from Somatic Mutations in a Single Cell